Schizosaccharomyces pombe Uncharacterized Protein C1A6.05c (SPAC1A6.05c) is a protein in the fission yeast Schizosaccharomyces pombe. Genes including SPCC1450.16c, SPAC1786.01c, and SPAC1A6.05c show a high level of homology to Saccharomyces cerevisiae TG lipase genes, namely TGL3, TGL4, and TGL5 .
SPAC1A6.05c is a triacylglycerol lipase involved in the mobilization of triacylglycerols in S. pombe .
Deletion of the SPAC1A6.05c gene in S. pombe leads to an increase in triglyceride content, suggesting its involvement in TG metabolism . Deletion of each gene (SPCC1450.16c, SPAC1786.01c and SPAC1A6.05c) increased TG content by approximately 1.7-fold compared to the parental wild-type strain, and their triple deletion mutant further increased TG content to 2.7-fold of the wild-type strain, suggesting that all three genes encode TG lipase and are functioning in S. pombe .
The triple deletion mutant (SPCC1450.16c, SPAC1786.01c and SPAC1A6.05c) shows sensitivity to cerulenin, an inhibitor of fatty acid synthesis, which can be restored by adding oleic acid in media .
SPAC1A6.05c shows homology to triglyceride lipase genes found in Saccharomyces cerevisiae, indicating a conserved function across different yeast species .
Loss of S. pombe lac1 results in multidrug sensitivity . Loss of both rav1 and lac1 is additive, as the double mutants exhibited greater drug sensitivity than either single mutant, suggesting that Rav1 and Lac1 act in different pathways to influence innate drug resistance .
Loss of S. pombe lac1 results in heat shock sensitivity and disruption of plasma membrane sterol distribution .
In growing cells, sterols are detected at the plasma membrane and enriched specifically at the growing tips of the cell and also at the site of cytokinesis in cells undergoing division . Strikingly, in lac1Δ mutant cells, but not rav1Δ and lag1Δ mutant cells, the pattern of filipin fluorescence was distributed evenly around the entire cell, suggesting that the structure of the plasma membrane is abnormal in this mutant .
KEGG: spo:SPAC1A6.05c
STRING: 4896.SPAC1A6.05c.1
Multiple expression systems can be employed for the recombinant production of SPAC1A6.05c, each with distinct advantages depending on your experimental goals. The table below summarizes the major expression platforms and their characteristics:
| Expression System | Advantages | Limitations | Suitable Applications |
|---|---|---|---|
| E. coli | High yield, simple culture conditions, economical, rapid expression | Limited post-translational modifications, potential inclusion body formation | Basic structural studies, antibody production, preliminary activity assays |
| Yeast (S. cerevisiae, P. pastoris) | Eukaryotic PTMs, high-density cultures, proper folding of eukaryotic proteins | Longer expression time than E. coli, hypermannosylation | Functional studies, structural analysis requiring authentic folding |
| Insect cells (Sf9, Sf21, High Five) | Complex eukaryotic PTMs, high expression of membrane proteins | Technical expertise required, higher cost than microbial systems | Structural biology of complex proteins, interaction studies |
| Mammalian cells (293T, CHO, etc.) | Human-like PTMs, authentic folding | Highest cost, longer timeline, technical complexity | Detailed functional assays, therapeutic protein development |
The choice of tag position and fusion partner significantly impacts expression, solubility, and downstream applications. His-tags facilitate purification via metal affinity chromatography, while larger fusion partners like MBP, GST, or trxA can enhance solubility .
Optimization of SPAC1A6.05c expression requires systematic evaluation of multiple parameters:
Expression Optimization:
Codon optimization: Analyze the codon usage in SPAC1A6.05c and adapt it to the expression host. This is particularly important when expressing S. pombe proteins in E. coli or mammalian systems .
Induction conditions: For E. coli expression, test various IPTG concentrations (0.1-1.0 mM), induction temperatures (16-37°C), and induction durations (4-24 hours). Lower temperatures (16-25°C) often improve solubility of eukaryotic proteins.
Media composition: Enriched media such as TB or auto-induction media can significantly increase yields compared to standard LB medium.
Fusion tags selection: Test different fusion partners:
Purification Strategy:
Initial capture: Immobilized metal affinity chromatography (IMAC) for His-tagged proteins
Intermediate purification: Ion exchange chromatography based on SPAC1A6.05c's theoretical pI
Polishing step: Size exclusion chromatography
Buffer optimization: Screen different pH values (7.0-8.5) and salt concentrations (50-500 mM) to maintain stability
The optimal storage buffer for purified SPAC1A6.05c includes Tris/PBS-based buffer with 6% trehalose at pH 8.0. For long-term storage, add 5-50% glycerol (final concentration) and store aliquots at -20°C/-80°C to avoid repeated freeze-thaw cycles .
As SPAC1A6.05c is predicted to function as a triacylglycerol lipase, multiple complementary approaches should be employed to characterize its enzymatic activity:
Lipase Activity Assays:
Spectrophotometric assays:
p-nitrophenyl ester hydrolysis (pNP-esters with varying acyl chain lengths)
pH-indicator based assays monitoring fatty acid release
Fluorogenic substrate assays (e.g., 4-methylumbelliferyl-based substrates)
Radiometric assays:
[³H]-labeled or [¹⁴C]-labeled triacylglycerol substrates followed by thin-layer chromatography separation
Natural substrate analysis:
Gas chromatography-mass spectrometry (GC-MS) for fatty acid release quantification
HPLC-based methods for glyceride analysis
Enzyme Kinetics Parameters:
Set up assays with varying substrate concentrations to determine:
Km (substrate affinity)
kcat (turnover number)
kcat/Km (catalytic efficiency)
Inhibition constants with known lipase inhibitors
Substrate Specificity Profiling:
Test activity against various lipid substrates to create a specificity profile:
Triacylglycerols with different fatty acid compositions
Diacylglycerols
Monoacylglycerols
Phospholipids
Cholesteryl esters
Compare the activity profile with other characterized lipases to position SPAC1A6.05c within the lipase functional classification .
Genetic interaction data from E-MAP (Epistatic Miniarray Profile) studies provide valuable insights into the functional context of SPAC1A6.05c:
Significant Genetic Interactions of SPAC1A6.05c (ptl3):
| Interacting Gene | Systematic ID | Interaction Score | Function |
|---|---|---|---|
| brc1 | Not specified | 2.2921 | DNA repair protein |
| msh2 | SPBC19G7.01C | 2.3301 | MutS protein homolog 2 |
| csi1 | SPBC2G2.14 | 2.1446 | Chromosome segregation protein |
| erg5 | SPAC19A8.04 | 2.2957 | C-22 sterol desaturase |
These positive genetic interactions (synthetic rescue or positive epistasis) suggest that SPAC1A6.05c may have functional relationships with DNA repair pathways, chromosomal maintenance, and sterol metabolism in S. pombe .
To interpret these results:
Pathway analysis: Look for enriched biological processes among interacting genes
Literature integration: Connect identified interactions with known lipid metabolism roles
Validation experiments: Confirm genetic interactions through double mutant growth assays
Mechanistic investigation: Explore how lipid metabolism might connect to DNA repair and chromosomal processes
This approach can generate hypotheses about SPAC1A6.05c's role beyond its predicted lipase function, potentially revealing moonlighting functions or metabolic connections between lipid homeostasis and genome maintenance .
Loss-of-Function Approaches:
CRISPR-Cas9 gene knockout:
Design guide RNAs targeting early exons of SPAC1A6.05c
Include repair templates with selectable markers
Confirm deletions via PCR, sequencing, and Western blotting
Assay for lipid metabolism phenotypes (lipid droplet accumulation, fatty acid composition)
RNAi-mediated knockdown:
Design dsRNA targeting SPAC1A6.05c with minimal off-target effects
Validate knockdown efficiency by RT-qPCR and Western blotting
Compare phenotypes with complete knockout to identify dosage-sensitive functions
Degron tagging for conditional depletion:
Tag endogenous SPAC1A6.05c with auxin-inducible degron
Use time-course experiments to track acute versus chronic effects of protein loss
Gain-of-Function Approaches:
Overexpression strategies:
Use strong promoters (e.g., nmt1 promoter) for constitutive expression
Employ inducible promoters for temporal control
Create expression constructs with and without tags to assess tag interference
Structure-function analysis:
Generate predicted catalytic site mutants (e.g., serine → alanine in the catalytic triad)
Create chimeric proteins with other characterized lipases
Express truncated versions to identify functional domains
Reporter systems:
Fusion with fluorescent proteins for localization studies
Split reporter systems for interaction studies
Experimental Controls:
Genetic background controls:
Isogenic wild-type strains
Complementation with wild-type SPAC1A6.05c to confirm phenotype specificity
Pathway controls:
Knockout/overexpression of other known lipases
Chemical inhibition of lipid metabolism pathways
Technical controls:
Understanding the subcellular localization of SPAC1A6.05c is crucial for elucidating its biological function. Multiple complementary techniques can be employed:
Fluorescent Protein Tagging:
C-terminal versus N-terminal tagging considerations:
Analyze protein domains to avoid disrupting targeting sequences
Test both orientations to determine optimal tag position
Consider using smaller tags (e.g., mNeonGreen) if standard GFP disrupts function
Endogenous tagging versus overexpression:
Endogenous tagging preserves native expression levels and regulation
CRISPR-Cas9 can facilitate precise integration of fluorescent tags
Validate functionality of tagged protein through complementation assays
Co-localization markers:
Include markers for organelles (mitochondria, endoplasmic reticulum, lipid droplets)
Use different fluorophores for multi-color imaging
Consider time-lapse imaging to track dynamic localization
Immunofluorescence:
Custom antibody generation:
Identify unique epitopes in SPAC1A6.05c
Validate antibody specificity using knockout controls
Optimize fixation and permeabilization conditions for S. pombe
Epitope tagging for commercial antibodies:
Add small epitope tags (HA, FLAG, Myc) to SPAC1A6.05c
Validate detection using commercial antibodies
Biochemical Fractionation:
Differential centrifugation:
Separate major cellular compartments (nucleus, mitochondria, microsomes, cytosol)
Track SPAC1A6.05c distribution using Western blotting
Density gradient separation:
Further resolve organelles based on density
Correlate SPAC1A6.05c presence with known organelle markers
Membrane association studies:
Treatment with detergents, high salt, or alkaline pH to discriminate between peripheral and integral membrane proteins
Determine if SPAC1A6.05c behaves as a soluble or membrane-associated protein
Data Integration:
Combine microscopy and biochemical approaches to create a comprehensive localization profile, considering that SPAC1A6.05c may have multiple localizations or shuttle between compartments depending on cellular conditions .
As a predicted triacylglycerol lipase, SPAC1A6.05c likely plays a role in lipid metabolism. A comprehensive analysis would involve:
Lipidome Analysis:
Lipidomics comparison between wild-type and SPAC1A6.05c mutants:
Use liquid chromatography-mass spectrometry (LC-MS) to analyze:
Triacylglycerol content and composition
Phospholipid profiles
Free fatty acid levels
Sterol content
Compare lipid profiles under different conditions (growth phases, carbon sources, stress conditions)
Lipid droplet analysis:
Nile Red or BODIPY staining for fluorescence microscopy
Quantitative image analysis for lipid droplet size, number, and distribution
Isolation of lipid droplets followed by proteomic and lipidomic analysis
Metabolic Flux Analysis:
Isotope labeling experiments:
Feed cells with ¹³C-labeled glucose or fatty acids
Track incorporation into lipid species over time
Compare flux patterns between wild-type and mutant strains
Respiratory measurements:
Oxygen consumption rates
Extracellular acidification rate
Substrate utilization patterns
Stress Response Connection:
Stress induction experiments:
Analyze SPAC1A6.05c expression and protein levels under:
Nutrient limitation
Oxidative stress
ER stress
Temperature stress
Determine if SPAC1A6.05c mutants show altered stress sensitivity
Growth phase analysis:
Monitor lipid metabolism changes through growth phases
Determine if SPAC1A6.05c is differentially regulated during stationary phase or quiescence
Pathway Interaction Studies:
Double mutant analysis:
Generate double mutants with other lipid metabolism genes
Analyze synthetic genetic interactions
Map SPAC1A6.05c within known metabolic pathways
Chemical-genetic interactions:
Understanding the protein interaction network of SPAC1A6.05c can provide crucial insights into its cellular functions and regulatory mechanisms:
Affinity Purification-Mass Spectrometry (AP-MS):
Tandem affinity purification:
Tag SPAC1A6.05c with dual affinity tags (e.g., FLAG-TEV-HA)
Perform sequential purification to reduce background
Identify interacting proteins by LC-MS/MS
Proximity-dependent biotin labeling:
BioID or TurboID fusion with SPAC1A6.05c
In vivo biotinylation of proximal proteins
Streptavidin pulldown followed by MS identification
Map the SPAC1A6.05c proximity interactome
Yeast-Based Interaction Assays:
Yeast two-hybrid screening:
Use SPAC1A6.05c as bait against S. pombe cDNA library
Screen for potential interaction partners
Validate through coimmunoprecipitation
Split-ubiquitin membrane yeast two-hybrid:
Particularly useful if SPAC1A6.05c has membrane association
Detect interactions in their native cellular context
In vitro Interaction Studies:
Pull-down assays with recombinant proteins:
Express and purify SPAC1A6.05c with affinity tag
Incubate with cell lysates or purified candidate proteins
Analyze binding by SDS-PAGE and Western blotting
Surface plasmon resonance (SPR) or bio-layer interferometry (BLI):
Determine binding kinetics and affinity constants
Characterize interaction dynamics with identified partners
Crosslinking Mass Spectrometry:
In vivo crosslinking:
Treat cells with membrane-permeable crosslinkers
Immunoprecipitate SPAC1A6.05c complexes
Identify crosslinked peptides by MS
XL-MS data analysis:
Map interaction interfaces at amino acid resolution
Generate structural models of complexes
Functional Validation:
Co-localization studies:
Perform dual-color imaging with identified interactors
Assess spatial and temporal co-localization patterns
Genetic interaction validation:
Researchers often encounter contradictory data when studying uncharacterized proteins like SPAC1A6.05c. Here's a methodological approach to resolving such contradictions:
Root Cause Analysis:
Experimental design differences:
Compare precise methodologies between contradictory studies
Identify variations in expression systems, tags, or assay conditions
Determine if differences in protein preparation affect folding or activity
Strain background effects:
Genetic differences between laboratory strains can influence phenotypes
Consider the potential impact of secondary mutations
Validate findings in multiple strain backgrounds
Technical variability:
Assess reproducibility within and between laboratories
Evaluate statistical analyses and sample sizes
Consider blinding and randomization protocols
Resolution Strategies:
Complementary methodologies:
Employ orthogonal techniques to address the same question
Combine in vitro biochemical assays with in vivo genetic approaches
Use both gain-of-function and loss-of-function studies
Condition-dependent functions:
Test function under different growth conditions
Consider cell cycle phases and metabolic states
Assess stress responses and environmental factors
Collaborative validation:
Establish collaborations with labs reporting conflicting results
Exchange materials, protocols, and expertise
Perform side-by-side experiments
Reconciliation Frameworks:
Multi-factorial models:
Develop models that incorporate seemingly contradictory data
Consider context-dependent functions or moonlighting activities
Explore regulatory mechanisms that might explain different observations
Unified hypothesis generation:
Formulate new hypotheses that account for all observations
Design critical experiments to test these unified hypotheses
Use computational approaches to integrate diverse datasets
Publication of contradictions:
Computational methods can generate testable hypotheses about SPAC1A6.05c function and interactions:
Sequence-Based Analysis:
Homology detection and evolutionary analysis:
PSI-BLAST and HHpred for remote homolog detection
Multiple sequence alignment to identify conserved residues
Phylogenetic profiling to identify co-evolving proteins
Domain and motif prediction:
InterProScan to identify functional domains
ELM for linear motif detection
SignalP, TMHMM, and TargetP for targeting sequence prediction
Structural prediction:
AlphaFold2 or RoseTTAFold for 3D structure prediction
Structure-based function prediction via I-TASSER or COACH
Active site prediction and comparison with known lipases
Network Analysis:
Protein-protein interaction prediction:
STRING database integration
Interolog mapping from model organisms
Co-expression network analysis using PomBase expression data
Genetic interaction network integration:
Analyze genetic interaction profiles from E-MAP studies
Compare with interaction profiles of known lipases
Identify functional modules and pathway connections
Pathway Mapping:
Metabolic pathway analysis:
Map SPAC1A6.05c to KEGG lipid metabolism pathways
Flux balance analysis in genome-scale metabolic models
Predict metabolic impacts of SPAC1A6.05c perturbation
Multi-omics data integration:
Incorporate transcriptomic, proteomic, and metabolomic datasets
Use Bayesian networks to infer causal relationships
Employ machine learning for function prediction from integrated data
Case Study: Predictive Analysis of SPAC1A6.05c:
Based on the available data, computational analysis suggests:
SPAC1A6.05c contains a lipase domain with the canonical catalytic triad
Structural modeling predicts an α/β-hydrolase fold typical of lipases
Network analysis places it in proximity to ergosterol biosynthesis pathways
Genetic interaction data connects it to stress response and DNA repair
Subcellular localization prediction suggests potential association with lipid droplets or membranes
These computational predictions generate specific hypotheses that can be experimentally tested .
Research on SPAC1A6.05c can provide valuable insights that translate to lipid metabolism in more complex organisms:
Evolutionary Conservation Analysis:
Homolog identification in model organisms:
Map SPAC1A6.05c homologs across evolutionary space
Determine if functional roles are conserved in:
S. cerevisiae and other fungi
C. elegans and Drosophila
Vertebrate models (zebrafish, mice)
Human cells
Conservation of regulatory mechanisms:
Compare transcriptional and post-translational regulation
Identify conserved protein-protein interactions
Assess pathway integration across species
Translational Research Applications:
Disease model connections:
Link findings to lipid storage disorders
Explore connections to metabolic diseases
Investigate potential roles in cancer metabolism
Cross-species validation:
Test if human homologs complement S. pombe SPAC1A6.05c deletion
Compare biochemical properties of recombinant proteins
Analyze cellular phenotypes in human cell culture models
Methodological Translation:
Assay development:
Adapt successful S. pombe-based assays for higher eukaryotes
Develop high-throughput screening approaches
Create biosensors based on SPAC1A6.05c function
Therapeutic relevance:
Explore potential druggability of human homologs
Assess metabolic pathway targeting strategies
Consider lipid metabolism modulation approaches
Case Study: From Yeast to Human Systems:
S. pombe has proven to be an excellent model for translational research, particularly in cell cycle regulation and stress response. Studies of SPAC1A6.05c could follow a similar trajectory:
Define basic function and regulation in S. pombe
Identify human homologs and conserved features
Test functional conservation in human cells
Explore roles in disease contexts
Develop therapeutic strategies if relevant
The compact genome and genetic tractability of S. pombe make it an ideal system for discovering fundamental principles that can later be validated in more complex organisms .
Recombinant protein production is essential for biochemical and structural studies, but researchers must carefully consider potential differences from the native protein:
Expression System Considerations:
Post-translational modifications:
Prokaryotic systems (E. coli) lack eukaryotic PTMs
Yeast systems may have different glycosylation patterns
Mammalian cells provide more human-like modifications
Compare PTM profiles between recombinant and native protein
Folding environment:
Assess proper folding using circular dichroism
Compare thermal stability between recombinant and native forms
Consider chaperone co-expression for complex proteins
Fusion Tag Effects:
Functional interference:
Test if tags affect enzyme kinetics or substrate binding
Compare tagged and untagged versions where possible
Assess if tag removal restores native-like properties
Structural considerations:
Evaluate if tags influence oligomerization or complex formation
Use small tags (His) or cleavable tags for structural studies
Position tags to minimize interference with functional domains
Validation Strategies:
Activity comparison:
Develop assays to compare recombinant and native enzymatic parameters
Isolate native protein from S. pombe for side-by-side comparison
Assess substrate specificities and inhibitor sensitivities
Complementation testing:
Express recombinant protein in SPAC1A6.05c knockout strains
Determine if it rescues mutant phenotypes
Test different recombinant variants to map functional requirements
Analytical Approaches:
| Parameter | Native Protein Analysis | Recombinant Protein Analysis | Validation Method |
|---|---|---|---|
| Expression level | Western blot, proteomics | SDS-PAGE, Western blot | Quantitative comparison |
| Localization | Immunofluorescence, fractionation | GFP fusion, in vitro binding | Co-localization studies |
| Complex formation | Co-IP, BN-PAGE | In vitro reconstitution | Mass spectrometry |
| Enzymatic activity | Crude extracts, partial purification | Purified protein assays | Kinetic parameter comparison |
| Regulation | In vivo studies | In vitro reconstitution | Phosphorylation analysis |
By systematically addressing these considerations, researchers can confidently extrapolate findings from recombinant protein studies to the native cellular context .
Several cutting-edge technologies hold promise for elucidating SPAC1A6.05c's role in S. pombe biology:
Advanced Imaging Technologies:
Super-resolution microscopy:
PALM/STORM for nanoscale localization
SIM for improved resolution of dynamic processes
Track SPAC1A6.05c in relation to lipid droplets and membranes
Correlative light and electron microscopy (CLEM):
Combine fluorescence localization with ultrastructural context
Visualize SPAC1A6.05c in relation to cellular compartments
Detect changes in membrane architecture in mutants
Live-cell metabolic imaging:
Fluorescent fatty acid analogs to track lipid metabolism
FRET-based sensors for metabolic intermediates
Real-time visualization of enzymatic activity
Genomic and Proteomic Advances:
CRISPR screens with single-cell readouts:
Genome-wide screens for genetic interactions
Single-cell transcriptomics to classify phenotypes
Multiplexed reporter systems for pathway activities
Proximity proteomics advancements:
TurboID or Split-TurboID for temporal control
Organelle-specific proximity labeling
Quantitative interaction dynamics
Proteome-wide structural studies:
In-cell NMR for structural dynamics
Hydrogen-deuterium exchange mass spectrometry
Crosslinking mass spectrometry for interaction interfaces
Computational and Systems Biology Approaches:
AI-driven protein function prediction:
Deep learning models integrating multiple data types
Improved structural predictions with AlphaFold2
Network-based function inference
Multi-scale modeling:
Molecular dynamics simulations of SPAC1A6.05c
Cell-scale metabolic models incorporating lipid dynamics
Population-level phenotypic modeling
Synthetic biology applications:
Designer lipid metabolism pathways
Biosensors based on SPAC1A6.05c activity
Minimal cell systems for pathway reconstitution
Translational Approaches:
Single-molecule enzymology:
Observe individual catalytic events
Characterize conformational dynamics
Detect heterogeneity in enzyme populations
Organoid and cell-type specific studies:
Transfer findings to more complex cellular contexts
Study tissue-specific functions of homologs
Explore metabolic compartmentalization
By integrating these emerging technologies, researchers can develop a comprehensive understanding of SPAC1A6.05c function in lipid metabolism and potentially discover unexpected roles in cellular processes .
Comparative proteomics offers powerful approaches to elucidate SPAC1A6.05c function through systematic analysis of protein expression, modification, and interaction changes:
Quantitative Proteomics Strategies:
Differential expression analysis:
Compare wild-type vs. SPAC1A6.05c deletion/overexpression strains
Use iTRAQ or TMT labeling for multiplexed quantification
Apply label-free approaches for broader coverage
Identify pathways affected by SPAC1A6.05c perturbation
Post-translational modification profiling:
Phosphoproteomics to detect signaling changes
Glycoproteomics for secretory pathway effects
Lipidomics to characterize changes in lipid profiles
Connect modifications to functional changes
Protein-protein interaction networks:
Affinity purification-mass spectrometry under various conditions
Compare interactome across growth phases and stress conditions
Identify condition-specific interaction partners
Experimental Design for Maximum Insight:
Temporal dynamics analysis:
Time-course experiments after genetic perturbation
Capture immediate vs. adaptive responses
Track protein expression changes during cell cycle progression
Subcellular proteomics:
Organelle isolation followed by proteomics
Track redistribution of proteins between compartments
Characterize composition of lipid droplets and membranes
Environment-specific responses:
Compare proteome changes under different carbon sources
Analyze stress response mechanisms
Identify condition-specific functions
Data Integration Framework:
Comparative proteomics generates massive datasets that require sophisticated integration:
Multi-omics integration:
Combine proteomics with transcriptomics and metabolomics
Correlate protein changes with metabolite profiles
Identify regulatory networks through integrated analysis
Pathway enrichment and network analysis:
Map changed proteins to known pathways
Identify enriched biological processes
Construct protein-protein interaction networks
Evolutionary conservation mapping:
Compare proteome responses across species
Identify conserved and divergent functional modules
Map human ortholog functions based on yeast findings
Case Study: Proteome Analysis in S. pombe:
Previous proteome analyses in S. pombe have successfully revealed:
Changes in protein levels across numerous biological pathways
Targets for genetic engineering to improve protein secretion
Connections between amino acid biosynthesis and membrane fluidity
Novel roles for previously uncharacterized proteins
Similar approaches could position SPAC1A6.05c within specific metabolic or signaling networks and identify unexpected functional connections .
By applying comprehensive proteomics approaches, researchers can develop testable hypotheses about SPAC1A6.05c function that integrate molecular mechanisms with cellular physiology and systems-level understanding.